KRAS is the most frequently mutated oncogene, and KRAS mutations are well-validated drivers of oncogenesis 1. As such, significant effort has been focused on developing direct inhibitors of KRAS and ...
Aminoacyl-tRNA synthetases (AARSs), a family of essential protein synthesis enzymes, are attractive targets for drug development. Although several different types of AARS inhibitors have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results